Solid-Phase Synthesis of Pyrrole-Imidazole Polyamides by Resin

Abstract:

Over the past years, synthesis of pyrrole-imidazole (Py-Im) polyamides has been achieved by solution-phase and solid-phase methods. Comparing with solution-phase synthesis, the solid-phase synthesis has showed great superiority in various aspects. The solid-phase synthesis is a rapid, effective, energy-saving and environment-friendly method, which has been widely used in the synthesis of pyrrole-imidazole polyamides. Many complicated polyamides can be obtained quickly and effectively through this method. By far, the application of the solid-phase synthesis for Py-Im polyamides has made rapid development. Resin as the main carrier, a key substance in solid phase synthesis, consists of two parts: polymer (macromolecular resin) and linking chain (linker). To date, there are many kinds of resins applied in the solid phase synthesis, such as PAM resin, Wang resin, Oxime resin and Clear resin, and so on. In this article, we will focus on the elaboration about the basic principle and application of the four kinds of resins mentioned above in solid-phase synthesis of polyamides. This provides an important reference for development of polyamides.

• Periodical: Advanced Materials Research (Volume 908)
• Pages: 215-219
• DOI: https://doi.org/10.4028/www.scientific.net/AMR.908.215
• Online since: March 2014
• Authors: Li Ying Mo, Yan Ling Wu, Min Rui Liu, Xing Lai Chen, Yan Ping Ding, Wen Zhang*
• Keywords: Py-Im Polyamide, Resin, Solid Phase Synthesis

References

[1] P. B. Dervan: Bioorg Med Chem 9 (2001), pp.2215-2235. (b) T. Bando and H. Sugiyama: Acc Chem Res 39 (2006), pp.935-944.

[2] R. S. Edayathumangalam, P. Weyermann, et al. Proc Natl Acad Sci USA 101 (2004) pp.6864-6869. (b) Y. W. Han, T. Matsumoto, et al. Nucleic Acids Res 40(22) (2012), pp.11510-11517.

[3] P. B. Dervan and B. S. Edelson: Curr Opin Struct Biol 13(3) (2003), pp.284-299. (b) P. B. Dervan, A. T. Poulin-Kerstien, et al. Top Curr Chem 253 (2005), pp.1-31.

[4] S. White, J. W. Szewczyk, et al. Nature 391 (1998), pp.468-471.

[5] W. Zhang, T. Bando, et al. J Am Chem Soc 128(27) (2006), pp.8766-8776.

[6] W. Zhang, M. Minoshima, et al. J Am Chem Soc 128(46) (2006), pp.14905-14912.

[7] W. Zhang, S. K. Jiang, et al. ChemBioChem 13 (2012), pp.47-50.

[8] H. F. Zhang, Y. L. Wu, et al. ChemBioChem 13 (2012), pp.1366-1374.

[9] H. Matsuda, N. Fukuda, et al. J Am Soc Nephrol 17 (2006), pp.422-432. (b) J. A. Raskatov, N. G. Nickols, et al. Proc Natl Acad Sci USA 109 (2012), pp.16041-16045. (c) D. M. Chenoweth, J. L. Meier, et al. Angew Chem Int Ed 54 (2013), pp.415-418.

[10] H. Matsuda, N. Fukuda, et al. Kidney Int 79 (2011).

[11] D.M. Chenoweth, D. A. Harki, et al. J Am Chem Soc 131(20) (2009), pp.7175-7181. (b) B. C. Li, D. C. Montgomery, et al. J Org Chem 78(1) (2013), pp.124-133.

[12] E. E. Baird, P. B. Dervan, et al. J Am Chem Soc 118 (1996), pp.6141-6146.

[13] C. J. Chou, M. E. Farkas, et al. Mol Cancer Ther 7(4) (2008), pp.769-778.

[14] N. R. Wurtz, J. M. Turner, et al. Org Lett 3 (2001), pp.1201-1203.

[15] P. B. Dervan and E. E. Baird: U. S. Patent 6, 545, 162B1. (2003).

[16] V. K. Sarin, S. B. H. Kent, et al. J Am Chem Soc 102(17) (1980), pp.5463-5470.

[17] Bogdan, J. Cristian, et al. J Am Chem Soc 125(16) (2003), pp.4741-4751.

[18] J. M. Belitsky, D. H. Nguyen, et al. Bioorg Med Chem 10(8) (2002), pp.2767-2774.

[19] R. Lazny, A. Nodzewska, et al. J Comb Chem 7(1) (2005), 109-116.

[20] K. Maria and B. George: J Am Chem Soc 118 (1996), pp.7083-7093.

[21] N. G. Nickols, J. O. Szablowski, et al. Mol Cancer Ther 12(5) (2013), pp.675-684.

[22] T. Vaijayanthi, T. Bando, et al. Bioorg Med Chem 21(4) (2013), pp.852-855.